Trial site
Jieyang People's Hospital
- 10running trials
- 9closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Head and neck cancer3 trials
- Metastatic breast cancer3 trials
- Chronic rhinosinusitis with nasal polyps2 trials
- Ankylosing spondylitis1 trial
- Aortic stenosis1 trial
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Diabetic eye disease1 trial
- Gastric and oesophageal cancer1 trial
- IgA nephropathy1 trial
- Lupus (SLE)1 trial
- Macular degeneration1 trial
- Phase
- Phase 35 trials
- Phase 24 trials
- Early phase 11 trial
- Phase 1/21 trial
- Phase 41 trial
- Status
- Completed8 trials
- Not yet recruiting5 trials
- Active, not recruiting3 trials
- Recruiting2 trials
- Withdrawn1 trial
- Lead sponsor
- Nanfang Hospital, Southern Medical University3 trials
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2 trials
- Shanghai Henlius Biotech2 trials
- Sun Yat-sen University2 trials
- argenx1 trial
- and 9 more
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Enhanced External Counter Pulsation on Afterload Mismatch Rate in Post-TEER (PAMPER)
Recruiting
Plasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral Mucositis
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Aortic Valve Diseases RISk facTOr assessmenT and Prognosis modeL Construction
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Head and neck cancer3 recruiting
- Aortic stenosis1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Withdrawn
Completed
A Clinical Study of JS005 in Patients With Ankylosing Spondylitis
Completed
Completed
A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps
Completed
Completed
Completed
Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026